Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial)
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Hematology"
DOI: 10.1002/ajh.24770
Abstract: The vast majority of children with sickle cell anemia (SCA) live in Africa, where evidence‐based guidelines for primary stroke prevention are lacking. In Kano, Nigeria, we conducted a feasibility trial to determine the acceptability of… read more here.
Keywords: trial; primary stroke; prevention children; stroke prevention ... See more keywords
Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Cardiology"
DOI: 10.1002/clc.23176
Abstract: Atrial fibrillation (AF) is an important preventable cause of stroke. Anticoagulation (AC) therapy can reduce this risk. However, prescribing patterns and outcomes in patients with non‐valvular AF (NVAF) from Latin American countries are poorly described. read more here.
Keywords: atrial fibrillation; non valvular; american countries; stroke prevention ... See more keywords
[Left atrial appendage closure for stroke prevention in atrial fibrillation : An update].
Sign Up to like & getrecommendations! Published in 2020 at "Herz"
DOI: 10.1007/s00059-020-04930-2
Abstract: Atrial fibrillation (AF) is one of the most frequent causes of ischemic stroke. Without treatment the annual risk of ischemic stroke is on average approximately 5-6%/year in patients with atrial fibrillation, depending on the overall… read more here.
Keywords: atrial fibrillation; fibrillation; closure; atrial appendage ... See more keywords
[Secondary stroke prevention after TIA or ischemic stroke].
Sign Up to like & getrecommendations! Published in 2021 at "Herz"
DOI: 10.1007/s00059-021-05035-0
Abstract: Stroke is one of the main causes of mortality and permanent disability. Secondary prevention of stroke recurrence therefore has a high priority. Secondary prevention of ischemic stroke includes optimization of the lifestyle and diet, treatment of… read more here.
Keywords: ischemic stroke; secondary prevention; stroke prevention; prevention ... See more keywords
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Sign Up to like & getrecommendations! Published in 2020 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-020-06981-3
Abstract: Ischaemic stroke and systemic embolism are the major potentially preventable complications of atrial fibrillation (AF) leading to severe morbidity and mortality. Anticoagulation using vitamin K antagonists (VKA) or non-vitamin K oral anticoagulants (NOACs) is mandatory… read more here.
Keywords: cardiology; anticoagulants stroke; atrial fibrillation; stroke prevention ... See more keywords
New Insights into Stroke Prevention and Treatment: Gut Microbiome.
Sign Up to like & getrecommendations! Published in 2021 at "Cellular and molecular neurobiology"
DOI: 10.1007/s10571-021-01047-w
Abstract: Stroke, a lethal neurological disease, accounts for a grave economic burden on society. Despite extensive basic and clinical studies on stroke prevention, a precise effective treatment approach for stroke at this stage remains unavailable. The… read more here.
Keywords: treatment; gut microbiota; stroke prevention; prevention treatment ... See more keywords
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Epidemiology"
DOI: 10.1007/s10654-018-0415-7
Abstract: The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial fibrillation (AF). Direct comparisons between NOACs in trials are lacking, leaving an important… read more here.
Keywords: risk; safety; evidence; stroke prevention ... See more keywords
Unprotected discharge: absence of stroke prevention strategies in patients with atrial fibrillation admitted for bleeding
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-020-00903-x
Abstract: Patients with atrial fibrillation or flutter (AF) on anticoagulation (AC) for stroke prevention are at an increased risk of bleeding. A common clinical dilemma is deciding when to safely restart AC following a bleed. Although… read more here.
Keywords: atrial fibrillation; prevention strategies; stroke prevention; prevention ... See more keywords
PFO closure for secondary stroke prevention: is the discussion closed?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-018-1633-2
Abstract: Three previous reports of PFO closure for secondary stroke prevention failed to find any significant benefit. Recently however, three conflicting reports were published suggesting a benefit in select patients. Although we are enthusiastic for PFO… read more here.
Keywords: closure; pfo closure; stroke prevention; closure secondary ... See more keywords
Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2020 at "Current Cardiology Reports"
DOI: 10.1007/s11886-020-01388-w
Abstract: A novel permanent carotid filter device for percutaneous implantation was developed for the purpose of stroke prevention. In this review, we cover rationale, existing preclinical and clinical data, and potential future directions for research using… read more here.
Keywords: bilateral carotid; carotid; filter; stroke prevention ... See more keywords
Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2017 at "Advances in Therapy"
DOI: 10.1007/s12325-017-0616-6
Abstract: Atrial fibrillation (AF) is associated with significant risk of stroke and other thromboembolic events, which can be effectively prevented using oral anticoagulation (OAC) with either vitamin K antagonists (VKAs) or non-VKA oral anticoagulants (NOACs) dabigatran,… read more here.
Keywords: atrial fibrillation; risk; pharmacological non; stroke prevention ... See more keywords